Find answers to our most frequently asked questions.
If you don’t find the information you are looking for, please contact us, we are happy to help.
Various factors can result in a small varying percentage change from batch to batch, meaning, a particular batch may be slightly more potent or less potent than the average potency. We pride ourselves on our rigorous testing to provide consumers with the most accurate strengths to help make purchasing decisions. So be sure to check the label each time you purchase.
Cannabis grown in Emerald’s Saint-Eustache facility is hang-dried for optimal terpene profiles.
We offer our patients and recreational customers a selection of high-quality dried cannabis flowers, cannabis oils, fast-action sprays and sublingual tablets in various THC and CBD potencies. Our flower and oils come in a variety of Indica, Sativa and hybrid options. We are excited to introduce SYNC Tabs to our smoke-free portfolio.
At Emerald, all of our batches go through a two-week flushing period. This includes one week of very low nutrient solution feeding, followed by a week of pure water flush.
We grow a variety of strains at any given time, using our proprietary cultivation methods and select plant genetics to obtain enhanced cannabinoid and terpene profiles. We strive to continually offer multiple strains with varying THC and CBD levels, helping meet the needs of our customers.
St. Eustache, Quebec
Emerald’s vertically integrated 88,000 square foot indoor production facility, Verdélite, is located in St. Eustache, Québec and includes 21 highly-controlled-environment grow rooms and 16 processing rooms. The facility is focused on producing unique strains with potent cannabinoid ranges and robust terpene profiles. Each batch of dried flower is hand-harvested, hang dried and cured, dry trimmed, and hand packaged.
Tiny droplets of oil dispersed in water that won’t separate because of their small size and the addition of stabilizing emulsifiers into the solution. Emulsifiers cover the oil droplets in a water-loving coat, allowing the oil and water to remain in suspension. We use all-natural food-grade plant-derived emulsifiers.
Cannabinoids (THC & CBD) dissolve in fats and oils but not directly into water, making it difficult for the body to absorb them. The tiny droplets of cannabis oil found in nanoemulsions have a high surface area per unit of volume, making it easier for the molecules to absorb into the bloodstream – this is called “increased bioavailability.” Nanoemulsions, therefore, have faster and more predictable effects.
Nanoemulsions droplets are ten times smaller than droplets found in cannabis oil and edibles. The tiny nanoemulsion droplets are absorbed quickly into the mouth and stomach, bypassing the unpredictable digestive system and alteration in the liver. Nanoemulsion formulation can increase cannabinoid absorption by 65% compared to standard cannabis oils and edibles, making the effects faster and more predictable.
1) Remove tab
2) To unlock the top
3) Hold down the
child-proof lock and turn nozzle
counterclockwise at the same time
4) Press nozzle down to apply spray
under the tongue
5) Hold nanoemulsion under the
tongue for at least 5 seconds before
swallowing
6) Wait 15-20 mins for the onset of effects,
which last between 2-4 hours
7) Lock spray bottle after use
We’ve elevated our flavoured oils and nanoemulsion sprays with similar tasting plant-based terpenes that enhance user experience. Terpenes are organic compounds found in certain plants that have therapeutic effects.
All of our oil products are made with 100% organic coconut-derived carrier oil that is ethically sourced and cruelty-free, unlike standard palm oils. Coconut oil contains fatty acids that support healthy body functions.
In compliance with Health Canada’s new regulations, our new integrated dropper is an easy, mess-free way of enjoying SYNC oils. Simply twist o the child-resistant cap, turn and hold the bottle at a 75-degree angle, wait two seconds for the oil to start dispensing and dispense the required number of drops.
Myrcene is one of the most common terpenes found in cannabis and, along with the many other compounds found in the plant, contributes to the flavour and fragrance of the flower. Based on a careful review of the scientific literature, along with the deep cannabis expertise of many of our team members, we have identified a number of terpenes with evidence that they may impart complementary effects to the cannabinoids in our formulations. In the case of myrcene, scientific studies have shown it may have anti-inflammatory, analgesic, and anxiolytic properties(1).
(1)Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br. J. Pharmacol., 163(7), 1344. doi: 10.1111/j.1476-5381.2011.01238.x
The amount of active (CBD or THC) in our products may vary slightly from batch to batch. For the most accurate value, you can check the label on your product for the amount of CBD or THC “per activation,” this tells you the amount of each cannabinoid released with every spray.
Our oil products and nano sprays are both excellent choices depending on the experience you are looking for and your specific needs. Each offers unique advantages to allow our patients and customers to choose the right product. Compared to the oil products that you may be used to, you can expect to feel the effects from our Fast Action Nano Sprays in a shorter time period (around 15-20 minutes), with the effect lasting 2-3 hours. Whereas our oil products can be expected to be longer lasting (~6-8 hours), but may take longer for you to feel the initial effect.
Emerald Health Therapeutics Inc. is publicly traded on the TSX Venture Exchange (TSXV: EMH) and the OTC Market (OTCQX: EMHTF).
Computershare, toll free at 1.800.564.6253, website: www.computershare.com
You can purchase shares through your financial advisor or online broker. Emerald Health Therapeutics Inc. is publicly traded on the TSX Venture Exchange (TSXV: EMH) and the OTC Market Group (OTCQX: EMHTF).
Our 2020 AGM meeting took place on October 29, 2020. We have not announced a date for our 2021 AGM. To learn more about Emerald Health Therapeutics, please click here – thanks.
Please contact our transfer agent, Computershare, at toll free: 1.800.564.6253, or email us at Emerald for further assistance at invest@emeraldhealth.ca.
To learn more about Emerald Health Therapeutics, please click here – thanks.
Emerald Health Therapeutics Inc. is publicly traded on the TSX Venture Exchange (TSXV: EMH) and the OTC Market (OTCQX: EMHTF).
Although your application form may be submitted via fax, email, or mail, cannabis regulations requires all applicants to submit their original Medical Document via mail. The only exception is having your original Medical Document sent directly through your healthcare Practitioner by secure fax at 1-800-855-623-3325
Please mail your medical document to:
Emerald Health Therapeutics, PO box 24076, 310-777 royal oak drive, Victoria BC, V8X 4V1
We pride ourselves on every aspect of your customer experience with Emerald. From growing quality cannabis with our plant genetics to distributing our products to your door, our team works hard to make accessing your medical cannabis seamless. Plus, our client care team is available to help guide you through the process, answer any questions and ensure your needs are being met.
If you change your mind and no longer want to proceed with the registration, please notify us as soon as possible. Emerald will return your paperwork to you at your request if you have not yet been fully registered and approved. If your medical document was faxed, unfortunately we cannot return it to you. If you have already been registered and approved with us, Emerald is required to keep the original Medical Document, and we will send you confirmation of your cancellation. If you wish to transfer your medical document simply send us an email to clients@emeraldhealth.ca requesting the transfer and where you would like us to transfer you to.
Illegal to cross Canadian borders
But it’s important to remember that, even after that date, it will remain illegal to travel across the border and internationally with cannabis (marijuana) in your possession. The Canadian Border and Services Agency recommends that you “don’t bring it in, don’t take it out.”
Flights within Canada – Possible Diversions
In the case of a domestic flight, please be advised that unforeseen situations may and do arise that require a domestic flight to divert to a U.S. airport, where arriving in possession of cannabis is not legal.
If you are refused entry into a country because you have cannabis in your possession, you alone will be responsible for the consequences, including for payment of your return trip home.
The following Government of Canada links offer useful information on cannabis and travel:
Yes. You can mix products to find the combination of strains or dosage that’s right for you. Some patients find it helpful to use different strains during the day and evening.
Although researchers have proven that the THC in cannabis degrades over time, there is no data yet to suggest that the product has a firm expiration date. Emerald suggests that you store your medical cannabis in a sealed container and in a cool, dark location.
According to published surveys, it has been suggested that the majority of people using both inhaled or orally ingested cannabis strictly for medicinal purposes reported using an average of 0.5 to 3 grams per day.
Under the federal Cannabis Act, adults who are 18 years of age or older can legally possess cannabis within certain limits. It is important to note that although the federal minimum age for possession of cannabis in public is 18, most provinces and territories have raised the minimum age requirement to 19. In Quebec, the age is 21.
Individuals who have attained the legal age of possession in their province can legally possess the following:
No. Emerald strongly advises that people avoid driving motor vehicle or operating any sort of heavy machinery while under the influence of cannabis as there are legal and safety implications.
Emerald offers free Canada Post Express shipping on orders over $125.00. There’s a $15.00 fee for orders under $125.00. Purolator is available at a flat rate of $25.00 per shipment. Explore Emerald’s product range.
Emerald primarily uses Canada Post XpressPost. We do offer Purolator at a premium. Please note that Purolator does not ship to PO Boxes.
Our products are shipped in discreet shipping bags or boxes.
Emerald aims to ships orders out of facility within one business day. Your package will usually arrive one to two business days later. Exceptions include when a patient lives in a remote delivery area. Due to current situations beyond our control shipments may be delayed due to COVID.
After you’re fully registered you can order online through the client shopping portal using your Emerald Client ID or call toll free to order at 1.800.757.3536 ext 1. Explore Emerald’s product range.
Yes, please call our Client Care team at 1.800.757.3536 ext 1.
Emerald understands that some medical cannabis users may be dealing with financial difficulties due to their health and conditions. To help ease the burden on our patients we offer compassion pricing for those who fit our criteria. To learn more, please contact our Client Care team at 1.800.757.3536 ext 1 or email clients@emeraldhealth.ca . Explore Emerald’s product range.
Emerald accepts most credit cards, pre-paid credit cards and credit card gift cards, including Visa, Mastercard, Visa Debit, Visa Gift Card. We also accept both e-transfer and cheques. If you choose to pay for your order via e-transfer or cheque, please call us toll free at 1.800.757.3536 ext 1 and we’ll assist you with placing your order. Please note that we cannot accept AMEX at this time
There is no minimum order, however all orders over $125 receive free shipping. For orders under $125 there is a $15.00 fee and delivery rate. Explore Emerald’s product range. Please note that all orders shipped with Purolator will be charged a premium charge of 25.00 regardless of amount.
© Copyright 2020 | All Rights Reserved | Privacy Policy | Terms and Conditions | Whistleblower Policy
Mr. Bovenschen has over 16 years of progressive experience in financial management, project and operations management, strategy development and risk management. Before joining Emerald, he was a senior member of the construction joint venture responsible for the Riyadh metro project, a rapid transit system under construction in Saudi Arabia with a US$22B contract value. Mr. Bovenschen previously served in various management roles for Strukton, a leading construction and engineering firm in the Netherlands and earned a Master of Business Administration from Nyenrode Business University and a BBA from NCOI in Utrecht, Netherlands.
Ms. Wong has over 30 years of quality and regulatory management experience in pharmaceutical and life science companies regulated to Canadian, US, European and international requirements. She has been responsible for establishing quality systems and ensuring regulatory compliance through all phases of product development from GPP, GLP, GCP, GMP for cannabis, pharmaceuticals, medical devices, combination products and biologicals. She was previously Executive Director of Quality Assurance at Novelion Therapeutics (formerly QLT Inc.) and worked for life science companies including MDS Nordion, Cangene Corporation, and Biomira Inc. Ms. Wong earned a B.Sc. (Microbiology) from the University of Alberta.
Ms. Hepburn has over a decade of experience in accounting and finance and is an experienced manager of privately and publicly traded manufacturing and mining businesses operating in Canada and the USA. Prior to joining Emerald, Ms. Hepburn was the Director of Finance and Administration at bioLytical Laboratories Inc., a medical diagnostics manufacturer. Before that, she held controller positions at junior gold and silver mining companies Northern Vertex Mining Corp., Kootenay Silver Inc. and Theia Resources Ltd. Ms. Hepburn earned a BBA from Simon Fraser University and her certification from the Certified Management Accountants of British Columbia.
Mr. Bandali’s expertise in global operations, strategy development, driving innovation, M&A, and investment management has been developed over a 25-year career in the life sciences sector spanning contract clinical and research services, analytical instrumentation, lab services and venture capital.
He holds an Advanced Management Program Degree from Harvard Business School, a Master of Business Administration from McGill University, and a Bachelor of Science from the University of British Columbia. He is an innovative business leader who has built strategic and operating plans that have resulted in rapid growth and significant profitability enhancement. He has managed businesses and operations with a global footprint and has led teams of over 900 people.
Mr. Bandali’s previous experience includes serving as President, Early Phase Clinical Services and Translational Science, Syneos Health; President, Early Stage Development, as well as Chief Innovation Officer, inVentiv Health Clinical; Senior Vice President, Strategy and Business Development, AB Sciex and Molecular Devices (part of Danaher Corporation); Senior Vice President, Strategy, Legal and Corporate Development, MDS Analytical Technologies; and Vice President and General Manager, Global Early Stage Development, MDS Pharma Services. He was also Venture Partner and Vice President at MDS Capital and has served on the boards of private and public companies.